Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration
Abhishek Jauhari, Tanisha Singh, Saumya Mishra, et al.
Toxicological Sciences (2020) Vol. 176, Iss. 2, pp. 433-445
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 18
Mitochondria and its epigenetic dynamics: Insight into synaptic regulation and synaptopathies
Shiwangi Gupta, Abhinoy Kishore, Vikas Rishi, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 3
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases
Raya Kh. Yashooa, Elisa Duranti, Donatella Conconi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 626-626
Open Access | Times Cited: 2
MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
Yong Hui Nies, Nor Haliza Mohamad Najib, Wei Ling Lim, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 77
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 25
The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
Hanwen Zhang, Longping Yao, Zijian Zheng, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 811-811
Open Access | Times Cited: 28
Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective
Sutong Xu, Xi Zhang, Chenming Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
Jiale Liu, Wenjie Duan, Yushu Deng, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 3
Open Access | Times Cited: 14
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
Kamatham Pushpa Tryphena, Urati Anuradha, Rohith Kumar, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S187-S202
Open Access | Times Cited: 22
Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)
Zhenwang Ma, Hao Liang, Bingcheng Hu, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Open Access | Times Cited: 11
Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson’s Disease
Sanjeev Kumar Yadav, Abhishek Jauhari, Nishant K. Singh, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3527-3553
Closed Access | Times Cited: 11
MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets
Nour Shaheen, Ahmed Shaheen, Mahmoud Osama, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Melatonin Deficits Result in Pathologic Metabolic Reprogramming in Differentiated Neurons
Abhishek Jauhari, Adam C. Monek, Yalikun Suofu, et al.
Journal of Pineal Research (2025) Vol. 77, Iss. 2
Open Access
Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson’s Disease
Sanjeev Kumar Yadav, Anuj Pandey, Sana Sarkar, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1781-1798
Closed Access | Times Cited: 17
Understanding the roles and regulation of mitochondrial microRNAs (MitomiRs) in neurodegenerative diseases: Current status and advances
Bhaskar Jyoti Saikia, Juhi Bhardwaj, Sangita Paul, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111838-111838
Closed Access | Times Cited: 10
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease
Osama A. Mohammed, Mohammed S. Elballal, Ahmed A. El-Husseiny, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155023-155023
Closed Access | Times Cited: 10
MicroRNA‐29b‐3p degenerates terminally differentiated dopaminergic SH‐SY5Y cells by perturbation of mitochondrial functions
Sana Sarkar, Anuj Pandey, Sanjeev Kumar Yadav, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 7, pp. 1297-1316
Closed Access | Times Cited: 3
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease
Shubhra Acharya, Antonio Salgado‐Somoza, Francesca Maria Stefanizzi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6513-6513
Open Access | Times Cited: 26
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Shalini Mani, Geeta Swargiary, Radhika Chadha
Mitochondrion (2021) Vol. 57, pp. 270-293
Closed Access | Times Cited: 23
Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models
Aurélie de Rus Jacquet, A. Ambaw, Mitali A. Tambe, et al.
Food & Function (2021) Vol. 12, Iss. 23, pp. 11987-12007
Open Access | Times Cited: 23
Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation
Ji Hyun Lee, Kyu Min Kim, Eun Hee Jung, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14826-14826
Open Access | Times Cited: 7
Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA
Sanskriti Rai, Prahalad Singh Bharti, Rishabh Singh, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Regulation of Parkin expression as the key balance between neural survival and cancer cell death
Fátima E. Murillo-González, Rosario García-Aguilar, Libia Vega, et al.
Biochemical Pharmacology (2021) Vol. 190, pp. 114650-114650
Closed Access | Times Cited: 17
An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a
Navneet Ammal Kaidery, Manuj Ahuja, Sudarshana M. Sharma, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 7, pp. 580-594
Open Access | Times Cited: 15
Neurodevelopmental disorders and neurotoxicity: MicroRNA in focus
Abhishek Jauhari, Tanisha Singh, Sanjay Yadav
Journal of Chemical Neuroanatomy (2022) Vol. 120, pp. 102072-102072
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top